James Rothman - Net Worth and Insider Trading
James Rothman Net Worth
The estimated net worth of James Rothman is at least $143,971 dollars as of 2024-11-10. James Rothman is the Director of PhenomeX Inc and owns about 144,245 shares of PhenomeX Inc (CELL) stock worth over $143,971. Details can be seen in James Rothman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Rothman has not made any transactions after 2021-11-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Rothman
James Rothman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Rothman owns 2 companies in total, including PhenomeX Inc (CELL) , and Adhera Therapeutics Inc (ATRX) .
Click here to see the complete history of James Rothman’s form 4 insider trades.
Insider Ownership Summary of James Rothman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CELL | PhenomeX Inc | 2021-11-08 | director |
ATRX | Adhera Therapeutics Inc | 2008-06-10 | director |
James Rothman Latest Holdings Summary
James Rothman currently owns a total of 1 stock. James Rothman owns 144,245 shares of PhenomeX Inc (CELL) as of November 8, 2021, with a value of $143,971.
Latest Holdings of James Rothman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CELL | PhenomeX Inc | 2021-11-08 | 144,245 | 1.00 | 143,971 |
Holding Weightings of James Rothman
James Rothman Form 4 Trading Tracker
According to the SEC Form 4 filings, James Rothman has made a total of 3 transactions in PhenomeX Inc (CELL) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in PhenomeX Inc is the acquisition of 4,000 shares on November 8, 2021, which cost James Rothman around $97,400.
Insider Trading History of James Rothman
- 1
James Rothman Trading Performance
GuruFocus tracks the stock performance after each of James Rothman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Rothman is -67.37%. GuruFocus also compares James Rothman's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Rothman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Rothman's insider trading performs compared to the benchmark.
Performance of James Rothman
James Rothman Ownership Network
Ownership Network List of James Rothman
Ownership Network Relation of James Rothman
James Rothman Owned Company Details
What does PhenomeX Inc do?
Who are the key executives at PhenomeX Inc?
James Rothman is the director of PhenomeX Inc. Other key executives at PhenomeX Inc include Chief Financial Officer Mehul Joshi , director & Chief Executive Officer Siddhartha Kadia , and 10 percent owner Bird Mergersub Corp .
PhenomeX Inc (CELL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PhenomeX Inc (CELL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhenomeX Inc (CELL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PhenomeX Inc (CELL)'s detailed insider trading history can be found in Insider Trading Tracker table.
PhenomeX Inc Insider Transactions
James Rothman Mailing Address
Above is the net worth, insider trading, and ownership report for James Rothman. You might contact James Rothman via mailing address: 135 East 83rd Street, Apt. 15c, New York Ny 10028.